Annual Cash & Cash Equivalents
$9.24 M
-$11.76 M-55.99%
December 1, 2023
Summary
- As of February 7, 2025, CATX annual cash & cash equivalents is $9.24 million, with the most recent change of -$11.76 million (-55.99%) on December 1, 2023.
- During the last 3 years, CATX annual cash & cash equivalents has fallen by -$54.59 million (-85.53%).
- CATX annual cash & cash equivalents is now -85.53% below its all-time high of $63.83 million, reached on June 30, 2021.
Performance
CATX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$226.44 M
-$25.56 M-10.14%
September 1, 2024
Summary
- As of February 7, 2025, CATX quarterly cash and cash equivalents is $226.44 million, with the most recent change of -$25.56 million (-10.14%) on September 1, 2024.
- Over the past year, CATX quarterly cash and cash equivalents has increased by +$208.46 million (+1159.21%).
- CATX quarterly cash and cash equivalents is now -10.14% below its all-time high of $252.00 million, reached on June 1, 2024.
Performance
CATX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CATX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -56.0% | +1159.2% |
| 3 y3 years | -85.5% | +521.2% |
| 5 y5 years | +73.5% | +521.2% |
CATX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -85.5% | at low | -10.1% | +2351.2% |
| 5 y | 5-year | -85.5% | +286.2% | -10.1% | >+9999.0% |
| alltime | all time | -85.5% | -100.0% | -10.1% | -100.0% |
Perspective Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $226.44 M(-10.1%) |
| Jun 2024 | - | $252.00 M(+77.3%) |
| Mar 2024 | - | $142.12 M(+1438.4%) |
| Dec 2023 | $9.24 M(-56.0%) | $9.24 M(-48.6%) |
| Sep 2023 | - | $17.98 M(-36.5%) |
| Jun 2023 | - | $28.32 M(-22.3%) |
| Mar 2023 | - | $36.45 M(+92.0%) |
| Dec 2022 | $20.99 M(-62.4%) | - |
| Sep 2022 | - | $18.99 M(-66.0%) |
| Jun 2022 | - | $55.89 M(-5.1%) |
| Jun 2022 | $55.89 M(-12.4%) | - |
| Mar 2022 | - | $58.90 M(-2.4%) |
| Dec 2021 | - | $60.35 M(-2.2%) |
| Sep 2021 | - | $61.69 M(-3.3%) |
| Jun 2021 | $63.83 M(+2568.4%) | - |
| Jun 2021 | - | $63.83 M(-1.6%) |
| Mar 2021 | - | $64.84 M(+576.5%) |
| Dec 2020 | - | $9.59 M(+394.1%) |
| Sep 2020 | - | $1.94 M(-18.9%) |
| Jun 2020 | $2.39 M(-55.1%) | $2.39 M(-0.5%) |
| Mar 2020 | - | $2.40 M(-24.4%) |
| Dec 2019 | - | $3.18 M(-30.5%) |
| Sep 2019 | - | $4.58 M(-14.1%) |
| Jun 2019 | $5.33 M(+104.8%) | $5.33 M(+31.2%) |
| Mar 2019 | - | $4.06 M(+26.8%) |
| Dec 2018 | - | $3.20 M(+46.0%) |
| Sep 2018 | - | $2.19 M(-15.7%) |
| Jun 2018 | $2.60 M(-56.2%) | $2.60 M(+9.9%) |
| Mar 2018 | - | $2.37 M(-19.9%) |
| Dec 2017 | - | $2.95 M(-25.4%) |
| Sep 2017 | - | $3.96 M(-33.3%) |
| Jun 2017 | $5.93 M(-41.5%) | $5.93 M(+16.3%) |
| Mar 2017 | - | $5.10 M(-23.5%) |
| Dec 2016 | - | $6.67 M(-21.2%) |
| Sep 2016 | - | $8.46 M(-16.6%) |
| Jun 2016 | $10.14 M(+94.0%) | $10.14 M(+78.1%) |
| Mar 2016 | - | $5.69 M(+738.8%) |
| Dec 2015 | - | $678.90 K(-57.2%) |
| Sep 2015 | - | $1.59 M(-69.6%) |
| Jun 2015 | $5.23 M(-31.9%) | $5.23 M(+385.1%) |
| Mar 2015 | - | $1.08 M(-19.4%) |
| Dec 2014 | - | $1.34 M(-35.6%) |
| Sep 2014 | - | $2.08 M(-73.0%) |
| Jun 2014 | $7.68 M(+164.8%) | $7.68 M(-67.6%) |
| Mar 2014 | - | $23.70 M(+436.9%) |
| Dec 2013 | - | $4.41 M(-16.5%) |
| Sep 2013 | - | $5.28 M(+82.2%) |
| Jun 2013 | $2.90 M(+8.5%) | $2.90 M(-21.3%) |
| Mar 2013 | - | $3.68 M(-17.0%) |
| Dec 2012 | - | $4.44 M(-11.7%) |
| Sep 2012 | - | $5.03 M(+88.2%) |
| Jun 2012 | $2.67 M | $2.67 M(+5.9%) |
| Mar 2012 | - | $2.52 M(-25.3%) |
| Dec 2011 | - | $3.38 M(+112.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2011 | - | $1.59 M(-24.5%) |
| Jun 2011 | $2.11 M(+25.8%) | $2.11 M(-20.8%) |
| Mar 2011 | - | $2.67 M(-3.7%) |
| Dec 2010 | - | $2.77 M(+170.4%) |
| Sep 2010 | - | $1.02 M(-39.0%) |
| Jun 2010 | $1.68 M(-43.9%) | $1.68 M(-30.8%) |
| Mar 2010 | - | $2.43 M(-21.9%) |
| Dec 2009 | - | $3.11 M(-2.0%) |
| Sep 2009 | - | $3.17 M(+6.0%) |
| Jun 2009 | $2.99 M(-38.0%) | $2.99 M(-42.1%) |
| Mar 2009 | - | $5.16 M(+107.9%) |
| Dec 2008 | - | $2.48 M(-34.2%) |
| Sep 2008 | - | $3.78 M(-21.7%) |
| Jun 2008 | $4.82 M(-48.5%) | $4.82 M(+43.7%) |
| Mar 2008 | - | $3.35 M(-3.5%) |
| Dec 2007 | - | $3.48 M(-46.1%) |
| Sep 2007 | - | $6.45 M(-31.1%) |
| Jun 2007 | $9.36 M(+323.8%) | $9.36 M(-57.9%) |
| Mar 2007 | - | $22.21 M(+500.4%) |
| Dec 2006 | - | $3.70 M(-28.3%) |
| Sep 2006 | - | $5.16 M(+133.8%) |
| Jun 2006 | $2.21 M(-93.2%) | $2.21 M(-10.7%) |
| Mar 2006 | - | $2.47 M(+281.1%) |
| Dec 2005 | - | $648.70 K(+206.6%) |
| Sep 2005 | - | $211.60 K(>+9900.0%) |
| Jun 2005 | $32.59 M(>+9900.0%) | - |
| Mar 2005 | - | $0.00(0.0%) |
| Dec 2004 | - | $0.00(0.0%) |
| Sep 2004 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2004 | - | $0.00(0.0%) |
| Mar 2004 | - | $0.00(0.0%) |
| Dec 2003 | - | $0.00(0.0%) |
| Sep 2003 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2003 | - | $0.00(0.0%) |
| Mar 2003 | - | $0.00(0.0%) |
| Dec 2002 | - | $0.00(0.0%) |
| Sep 2002 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2002 | - | $0.00(0.0%) |
| Mar 2002 | - | $0.00(0.0%) |
| Dec 2001 | - | $0.00(0.0%) |
| Sep 2001 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2001 | - | $0.00(0.0%) |
| Mar 2001 | - | $0.00(-100.0%) |
| Dec 2000 | - | $100.00(>+9900.0%) |
| Sep 2000 | $0.00(0.0%) | $0.00(-100.0%) |
| Jun 2000 | - | $100.00(0.0%) |
| Mar 2000 | - | $100.00(0.0%) |
| Dec 1999 | - | $100.00(>+9900.0%) |
| Sep 1999 | $0.00(-100.0%) | $0.00 |
| Sep 1998 | $17.00 K(-44.8%) | - |
| Sep 1997 | $30.80 K(+5.5%) | - |
| Sep 1996 | $29.20 K(-9.0%) | - |
| Sep 1995 | $32.10 K(-92.5%) | - |
| Sep 1994 | $427.20 K | - |
FAQ
- What is Perspective Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Perspective Therapeutics?
- What is Perspective Therapeutics annual cash & cash equivalents year-on-year change?
- What is Perspective Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Perspective Therapeutics?
- What is Perspective Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Perspective Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of CATX is $9.24 M
What is the all time high annual cash & cash equivalents for Perspective Therapeutics?
Perspective Therapeutics all-time high annual cash & cash equivalents is $63.83 M
What is Perspective Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, CATX annual cash & cash equivalents has changed by -$11.76 M (-55.99%)
What is Perspective Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CATX is $226.44 M
What is the all time high quarterly cash and cash equivalents for Perspective Therapeutics?
Perspective Therapeutics all-time high quarterly cash and cash equivalents is $252.00 M
What is Perspective Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, CATX quarterly cash and cash equivalents has changed by +$208.46 M (+1159.21%)